Applied Clinical Trials
July 01, 2006
View from Washington
0
0
Payers seek more comparative drug data from sponsors and independent researchers.
July 01, 2006
View from Brussels
0
0
European Medicines Agency adopts new approach to drug development process.
July 01, 2006
Feature Article
0
0
This new course aims to provide clinical research physicians with good clinical practice knowledge.
July 01, 2006
Feature Article
0
0
Teaming up with a staffing partner can help companies find the right CRA for their trial.
July 01, 2006
Feature Article
0
0
Open-label extension (OLE) studies are common, but they do not receive as much attention as traditional Phase I through Phase IV studies. Enrollment into an OLE study typically follows enrollment into a randomized, blinded, well-controlled main study. Participants are usually informed at the time they are recruited into the main study that they may elect to enroll in an OLE study after completing the main trial. The stated objective of most OLE studies is to obtain long-term safety and tolerability data.
July 01, 2006
Feature Article
0
0
Electronic solutions can enhance the efficiency of tracking drugs throughout a clinical trial.
July 01, 2006
A Closing Thought
0
0
Right now the industry has a chance to reclaim its good name and recapture the public's respect for the power of what it can do.